Article Text

Download PDFPDF
Case report
Clinical improvement of severe COVID-19 pneumonia in a pregnant patient after caesarean delivery
  1. Margeaux Oliva1,
  2. Karen Hsu1,
  3. Sarah Alsamarai2,
  4. Vincent de Chavez2 and
  5. Lauren Ferrara3,4
  1. 1 Obstetrics and Gynecology, Icahn School of Medicine at Mount Sinai, New York, New York, USA
  2. 2 Infectious Disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA
  3. 3 Maternal Fetal Medicine, Obstetrics and Gynecology, Icahn School of Medicine at Mount Sinai, New York, New York, USA
  4. 4 Obstetrics and Gynecology, NYC Health and Hospitals Elmhurst, Elmhurst, New York, USA
  1. Correspondence to Dr Margeaux Oliva; margeaux.oliva{at}mountsinai.org

Abstract

The clinical implications of COVID-19 in pregnancy remain unknown. While preliminary reports demonstrate that pregnant patients have a similar symptomatic presentation to the general population, the appropriate management and timing of delivery in these patients is still unclear, as pregnancy may impose additional risk factors and impede recovery in gravid patients. In this brief report, we present a case of COVID-19 in a pregnant patient with severe respiratory compromise, whose clinical status significantly improved after caesarean delivery. We also address the potential benefits of experimental therapy, including tocilizumab, a monoclonal antibody that targets interleukin-6 receptors.

  • immunological products and vaccines
  • infectious diseases
  • obstetrics and gynaecology

This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

https://bmj.com/coronavirus/usage

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors MO, KH, SA, VC and LF all participated in the patient’s care. All authors contributed to the writing of the manuscript and approved the final manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.